Water → HCID 86713173, compound
Reaction equation
[NH2:1][C@H:2]([CH2:21][F:22])[C@@H:3]([C:5]1[CH:10]=[CH:9][C:8]([C:11]2[O:15][N:14]=[C:13]([CH2:16][S:17]([CH3:20])(=[O:19])=[O:18])[CH:12]=2)=[CH:7][CH:6]=1)[OH:4].C(N(C(C)C)CC)(C)C.[F:32][CH:33]([F:37])[C:34](Cl)=[O:35].O>CN(C)C=O>[F:32][CH:33]([F:37])[C:34]([NH:1][C@H:2]([CH2:21][F:22])[C@H:3]([OH:4])[C:5]1[CH:10]=[CH:9][C:8]([C:11]2[O:15][N:14]=[C:13]([CH2:16][S:17]([CH3:20])(=[O:18])=[O:19])[CH:12]=2)=[CH:7][CH:6]=1)=[O:35]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
(1R,2S)-2-amino-3-fluoro-1-(4-(3-(methylsulfonylmethyl)isoxazol-5-yl)phenyl)propan-1-ol (75 mg, 0.21 mmol) in dimethylformamide (2 mL) at 5° C. is treated with diisopropylethylamine (0.055 mL, 0.62 mmol) and then difluoroacetylchloride (0.026 mL, 0.25 mmol) is added and the mixture stirred at room temperature for 1 hour. Water is added (10 mL) and extracted with ethyl acetate (10 mL) and the organics washed with brine (10 mL), dried over MgSO4, filtered, concentrated and purified by reverse phase preparative HPLC to give the title compound (35 mg). 1H NMR (400 MHz, DMSO-d6) δ: 3.10 (s, 3H), 4.33 (m, 1H), 4.40-4.60 (m, 1H), 4.65-4.80 (m, 3H including 2H singlet at 4.75), 4.92 (bs, 1H), 6.17 (t, 1H), 7.08 (s, 1H), 7.51 (d, 2H), 7.86 (d, 2H), 8.80 (d, 1H); m/z (Cl) 407 [M+H].
Workup
- extractionextracted with ethyl acetate (10 mL)
- washthe organics washed with brine (10 mL)
- dry with materialdried over MgSO4
- filtrationfiltered
- concentrationconcentrated
- custompurified by reverse phase preparative HPLC
Sources & evidence
- ORD record
- ord-1ec75a2e760d42789943953351c1b405
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09206126B2
Reaction notes
Loading…